Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on March 9, 2026 [1] Group 1: Class Action Details - Investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - To serve as lead plaintiff, individuals must file a motion with the court by March 9, 2026 [3] Group 2: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming to employ an active monitoring process that was not actually utilized [5] - Defendants reportedly downplayed increased claim denials by third-party payors and did not write off uncollectible accounts, leading to inflated accounts receivable figures [5] - The firm also failed to maintain sufficient professional malpractice liability insurance, which was inadequate to cover claims arising from operations, particularly in the New Mexico market [5]
ARDT DEADLINE TOMORROW: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT